NO20002789D0 - Hydrofobisk-modifiserte proteinpreparater og fremgangsmÕter for fremstilling derav - Google Patents

Hydrofobisk-modifiserte proteinpreparater og fremgangsmÕter for fremstilling derav

Info

Publication number
NO20002789D0
NO20002789D0 NO20002789A NO20002789A NO20002789D0 NO 20002789 D0 NO20002789 D0 NO 20002789D0 NO 20002789 A NO20002789 A NO 20002789A NO 20002789 A NO20002789 A NO 20002789A NO 20002789 D0 NO20002789 D0 NO 20002789D0
Authority
NO
Norway
Prior art keywords
protein
processes
preparation
hydrophobically modified
modified protein
Prior art date
Application number
NO20002789A
Other languages
English (en)
Other versions
NO20002789L (no
Inventor
R Blake Pepinsky
Darren P Baker
Dingyi Wen
Kevin P Williams
Ellen A Garber
Frederick R Taylor
Alphonse Galdes
Jeffrey Porter
Original Assignee
Biogen Inc
Ontogeny Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc, Ontogeny Inc filed Critical Biogen Inc
Publication of NO20002789D0 publication Critical patent/NO20002789D0/no
Publication of NO20002789L publication Critical patent/NO20002789L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Analytical Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Graft Or Block Polymers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20002789A 1997-12-03 2000-05-31 Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav NO20002789L (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6742397P 1997-12-03 1997-12-03
US7893598P 1998-03-20 1998-03-20
US8968598P 1998-06-17 1998-06-17
US9980098P 1998-09-10 1998-09-10
PCT/US1998/025676 WO1999028343A2 (en) 1997-12-03 1998-12-03 Hydrophobically-modified protein compositions and methods

Publications (2)

Publication Number Publication Date
NO20002789D0 true NO20002789D0 (no) 2000-05-31
NO20002789L NO20002789L (no) 2000-08-02

Family

ID=27490628

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002789A NO20002789L (no) 1997-12-03 2000-05-31 Hydrofobisk-modifiserte proteinpreparater og fremgangsmater for fremstilling derav

Country Status (25)

Country Link
US (1) US6444793B1 (no)
EP (1) EP1036092B1 (no)
JP (1) JP4289788B2 (no)
KR (1) KR20010032753A (no)
CN (1) CN1294595A (no)
AT (1) ATE295372T1 (no)
AU (1) AU757497B2 (no)
BR (1) BR9815142A (no)
CA (1) CA2309806A1 (no)
CZ (1) CZ20002008A3 (no)
DE (1) DE69830192T2 (no)
DK (1) DK1036092T3 (no)
EA (1) EA003739B1 (no)
EE (1) EE200000308A (no)
ES (1) ES2243018T3 (no)
HU (1) HUP0100535A3 (no)
IL (2) IL136137A0 (no)
IS (1) IS2163B (no)
MX (1) MXPA00005494A (no)
NO (1) NO20002789L (no)
NZ (1) NZ504752A (no)
PL (1) PL197833B1 (no)
PT (1) PT1036092E (no)
TR (1) TR200001612T2 (no)
WO (1) WO1999028343A2 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999028454A1 (en) * 1997-11-28 1999-06-10 Roche Diagnostics Gmbh An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
US6897297B1 (en) 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
PT1036092E (pt) 1997-12-03 2005-09-30 Biogen Inc Compos~icoes e metodos de proteinas hidrofobicamente modificadas
ES2252886T3 (es) * 1998-04-30 2006-05-16 Curis, Inc. Conjugado de proteinas de erizo activo, proceso para su produccion y uso.
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
WO2000025725A2 (en) * 1998-11-02 2000-05-11 Biogen, Inc. Functional antagonists of hedgehog activity
EP1135411B1 (en) * 1998-12-03 2006-05-17 Curis, Inc. Methods and compositions for treating disorders involving excitotoxicity
EP1025861A1 (de) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Pharmazeutische Zusammensetzung von hydrophob modifizierten Hedgehog-Proteinen und deren Verwendung
AU782493B2 (en) * 1999-06-01 2005-08-04 Curis, Inc. Polymer conjugates of hedgehog proteins and uses
AU2005203058C1 (en) * 1999-11-05 2009-07-02 Curis, Inc. Hedgehog fusion proteins and uses
EP1230271A1 (en) * 1999-11-05 2002-08-14 Biogen, Inc. Hedgehog fusion proteins and uses
WO2001082994A1 (en) * 2000-04-28 2001-11-08 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
WO2003089454A2 (en) * 2002-04-19 2003-10-30 California Institute Of Technology Unnatural amino acid containing display libraries
EP1773375A1 (en) 2004-07-14 2007-04-18 University of Utah Research Foundation Netrin-related compositions and uses
US20090047282A1 (en) * 2005-03-25 2009-02-19 Hideaki Tojo Prophylactic/Therapeutic Agent for Cancer
CA2629346A1 (en) * 2005-11-11 2007-05-18 Proteogen Bio S.R.L. Method of converting water-soluble active proteins into hydrophobic active proteins, the use of the same for the preparation of monomolecular layers of oriented active proteins, and devices comprising the same
US8273747B2 (en) 2006-11-02 2012-09-25 Curis, Inc. Small organic molecule regulators of cell proliferation
KR100876657B1 (ko) * 2007-10-15 2009-01-07 한국기계연구원 표면개질된 마이크로비드와 마이크로비드 어레이칩의제조방법과 마이크로비드 어레이칩을 이용한 질병특이항원의 확인방법
CN101952306B (zh) * 2008-02-21 2014-09-10 皮护神经科学协会 Mntf肽的化妆和皮肤病制剂
US20100316566A1 (en) * 2008-02-27 2010-12-16 Radiomedix Inc. Radiolabeled hedgehog derivatives for imaging and therapy
UA107571C2 (xx) * 2009-04-03 2015-01-26 Фармацевтична композиція
CN103665095A (zh) * 2012-09-11 2014-03-26 中国人民解放军军事医学科学院卫生学环境医学研究所 一种疏水性多肽修饰抗体的合成方法
CN106924753B (zh) * 2015-12-30 2021-11-09 北京大学 制备蛋白质-聚氨基酸环状偶联物的方法
CN108147990B (zh) * 2016-12-02 2023-01-24 上海中医药大学 一种膜锚定元件及其应用
CN111787942B (zh) 2017-10-25 2024-03-29 杨森制药公司 磷酸化Tau肽的组合物及其用途
MY206596A (en) 2019-02-08 2024-12-25 Janssen Pharmaceuticals Inc Method of safe administration of phosphorylated tau peptide vaccine
JP2023136614A (ja) * 2022-03-17 2023-09-29 三菱ケミカル株式会社 植物を用いたヘッジホッグタンパク質の製造方法
CN116983461B (zh) * 2023-03-14 2025-07-22 中国石油大学(华东) 基于脂质体修饰的止血海绵体系
CN116549713B (zh) * 2023-05-09 2025-06-13 浙江大学 一种兼具组织粘合和防粘连的手术贴片和其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5409611A (en) * 1988-03-24 1995-04-25 Terrapin Technoogies, Inc. Method to identify analyte-binding ligands
US5130297A (en) 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
US5824315A (en) * 1993-10-25 1998-10-20 Anergen, Inc. Binding affinity of antigenic peptides for MHC molecules
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5869602A (en) * 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
CA2267106A1 (en) * 1996-10-07 1998-07-16 The Johns Hopkins University School Of Medicine Novel hedgehog-derived polypeptides
PT1036092E (pt) 1997-12-03 2005-09-30 Biogen Inc Compos~icoes e metodos de proteinas hidrofobicamente modificadas

Also Published As

Publication number Publication date
HK1030953A1 (en) 2001-05-25
DE69830192T2 (de) 2006-01-12
KR20010032753A (ko) 2001-04-25
AU1996699A (en) 1999-06-16
EE200000308A (et) 2001-10-15
US6444793B1 (en) 2002-09-03
DE69830192D1 (de) 2005-06-16
DK1036092T3 (da) 2005-08-15
ATE295372T1 (de) 2005-05-15
NZ504752A (en) 2002-10-25
EP1036092B1 (en) 2005-05-11
PL341430A1 (en) 2001-04-09
HUP0100535A2 (hu) 2001-06-28
EP1036092A2 (en) 2000-09-20
JP4289788B2 (ja) 2009-07-01
TR200001612T2 (tr) 2001-01-22
CN1294595A (zh) 2001-05-09
CA2309806A1 (en) 1999-06-10
WO1999028343A9 (en) 1999-10-14
ES2243018T3 (es) 2005-11-16
WO1999028343A3 (en) 1999-08-12
BR9815142A (pt) 2000-10-10
HUP0100535A3 (en) 2003-09-29
IL136137A (en) 2009-09-22
JP2001525336A (ja) 2001-12-11
PT1036092E (pt) 2005-09-30
IL136137A0 (en) 2001-05-20
MXPA00005494A (es) 2003-05-19
WO1999028343A2 (en) 1999-06-10
EA003739B1 (ru) 2003-08-28
AU757497B2 (en) 2003-02-20
CZ20002008A3 (cs) 2001-11-14
IS2163B (is) 2006-11-15
IS5499A (is) 2000-05-15
EA200000605A1 (ru) 2000-12-25
NO20002789L (no) 2000-08-02
PL197833B1 (pl) 2008-04-30

Similar Documents

Publication Publication Date Title
NO20002789D0 (no) Hydrofobisk-modifiserte proteinpreparater og fremgangsmÕter for fremstilling derav
Backes et al. An alkanesulfonamide “safety-catch” linker for solid-phase synthesis
Hou et al. Peptidyl N, N-bis (2-mercaptoethyl)-amides as thioester precursors for native chemical ligation
DE60120713D1 (de) Funktionelles protein array
EP1067182A8 (en) Secretory protein or membrane protein
ATE431834T1 (de) Prozess zur trennung von proteinen
KR870001237A (ko) 혈액응고 억제작용을 갖는 폴리펩티드의 분리 및 제조 방법
IL115199A (en) Composition comprising a polynucleic acid molecule in a liposome and method using said composition
BR9811675A (pt) Genes isolados para proteìna da membrana de célula dentrìtica
DK162233C (da) Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
WO1996038553A1 (en) A method for identification of biologically active peptides and nucleic acids
JP2004535152A (ja) 細胞培養物に対する成長影響活性を有するカゼインペプチドフラグメント
BR0016432A (pt) Molécula de ácido nucleico isolada, vetor, célula hospedeira, descendentes, sementes ou material celular reproduzìvel, método de produção de um ou mais polipeptìdeo(s), tcmrp isolada, polipeptìdeo isolado, anticorpo, kit de teste, método para produzir um produto quìmico fino, produto quìmico fino, e, uso de um produto quìmico fino ou de polipeptìdeo(s).
CY1105206T1 (el) Διαδικασια για την εκχυλιση και χρησιμοποιηση υγρου επωασης απο σολομο του ατλαντικου
BR0213779A (pt) Molécula de ácido nucleico isolada, vetor, célula hospedeira, e, método para a preparação de um composto de quìmica fina
Slaughter et al. Demonstration that bovine erythrocyte cytochrome b5 is the hydrophilic segment of liver microsomal cytochrome b5
NO984491L (no) SCF-analogpreparater og fremgangsmÕte for fremstilling av disse
WO1999028876A3 (en) Hydrophobically-modified protein compositions and methods
Ogishima et al. Partial amino acid sequences of two mitochondrial and two microsomal cytochrome P-450's from adrenal cortex
WO1999047673A3 (en) Isolated mammalian membrane protein genes and related reagents
Mamelok et al. Separation of membrane-bound. gamma.-glutamyl transpeptidase from brush border transport and enzyme activities
CY1105486T1 (el) Τροποποιημενες υδροφοβικα συνθεσεις πρωτεϊνων ακανθοχοιρου και μεθοδοι παρασκευης αυτων
WO2004033648A3 (en) Isolated mammalian membrane protein genes; related reagents
WO2000032746A3 (en) Netrin-like and ependymin-like nucleic acids and polypeptides and uses thereof
WO2001025430A3 (en) Novel human membrane proteins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application